Healthcare Realty Trust (NYSE:HR) Announces Earnings Results, Misses Expectations By $0.46 EPS

Healthcare Realty Trust (NYSE:HR) issued its quarterly earnings results on Thursday. The real estate investment trust reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of $0.41 by ($0.46), FiscalAI reports. Healthcare Realty Trust had a negative return on equity of 1.00% and a negative net margin of 3.96%. The business had revenue of $286.64 million for the quarter, compared to the consensus estimate of $275.27 million. During the same quarter last year, the business posted $0.41 earnings per share. The business’s revenue was down 3.4% compared to the same quarter last year.

Healthcare Realty Trust Stock Performance

Shares of HR opened at $18.45 on Friday. The stock has a market capitalization of $6.32 billion, a price-to-earnings ratio of -131.79 and a beta of 0.97. Healthcare Realty Trust has a 52-week low of $16.31 and a 52-week high of $22.04. The stock’s 50-day simple moving average is $18.17 and its 200 day simple moving average is $18.81.

Healthcare Realty Trust Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 20th. Investors of record on Tuesday, November 10th will be paid a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a dividend yield of 5.2%. The ex-dividend date is Tuesday, November 10th. Healthcare Realty Trust’s payout ratio is presently -369.23%.

Healthcare Realty Trust News Summary

Here are the key news stories impacting Healthcare Realty Trust this week:

• Positive Sentiment: Raised 2026 outlook: Healthcare Realty increased its normalized FFO guidance to $1.65–$1.67 per share, raising the midpoint by $0.02. Same-store cash NOI growth guidance was also lifted to 5.00%–5.25%, signaling improved expected property-level performance. Healthcare Realty Reports Third Quarter 2026 Results and Further Increases Full Year 2026 Guidance
• Positive Sentiment: FFO beat expectations: Third-quarter normalized funds from operations reached $0.42 per share, up from $0.41 a year earlier and above the $0.41 analyst consensus. FFO is a key valuation measure for REIT investors and helped offset concerns about the GAAP results. Healthcare Realty Trust Tops Q3 FFO and Revenue Estimates
• Positive Sentiment: Income return remains attractive: The company declared a quarterly dividend of $0.24 per share, or $0.96 annually, representing an indicated yield of approximately 5.3% based on the supplied trading data. Healthcare Realty Trust Dividend Information
• Neutral Sentiment: Share repurchase authorization: Reports referenced a $500 million equity buyback plan, which could support per-share value over time, although the plan dates back to 2025 and its current pace of execution was not specified. Healthcare Realty Trust Announces an Equity Buyback
• Negative Sentiment: GAAP results remained weak: HR reported a third-quarter loss of $0.05 per share versus $0.41 of earnings a year earlier, while revenue declined 3.4% year over year. The loss could limit enthusiasm if investors place greater weight on reported earnings than on adjusted FFO. Healthcare Realty Trust Third Quarter Earnings Results

Insider Activity

In other news, COO Robert Hull sold 21,000 shares of the company’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $19.11, for a total value of $401,310.00. Following the transaction, the chief operating officer owned 276,338 shares of the company’s stock, valued at approximately $5,280,819.18. This represents a 7.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.56% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on HR. Jefferies Financial Group began coverage on shares of Healthcare Realty Trust in a report on Tuesday, September 15th. They issued a “hold” rating and a $20.00 price target on the stock. UBS Group decreased their price objective on shares of Healthcare Realty Trust from $21.00 to $18.00 and set a “neutral” rating for the company in a report on Tuesday, October 13th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Healthcare Realty Trust in a research report on Wednesday. Royal Bank Of Canada boosted their target price on shares of Healthcare Realty Trust from $21.00 to $22.00 and gave the company a “sector perform” rating in a research note on Friday, August 7th. Finally, Cantor Fitzgerald increased their target price on shares of Healthcare Realty Trust from $22.00 to $24.00 and gave the company an “overweight” rating in a research report on Friday, July 31st. Five research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $21.36.

About Healthcare Realty Trust

Healthcare Realty Trust Incorporated (NYSE: HR) is a real estate investment trust focused on owning, managing, acquiring and developing outpatient healthcare properties. Its portfolio primarily includes medical office buildings, ambulatory surgery centers, outpatient facilities and other properties used by healthcare providers.

The company leases space to health systems, physician groups and other healthcare organizations, with properties generally located on or near hospital campuses and in growing outpatient care settings.